Columbus Circle Capital Corp II CMIIU
10.79 USD 0.00 (+0.00%)
At closeJul 7, 2026, 4:00 PM EDT
9.94 -0.85 -7.88%
After hours · Jul 7, 4:00 PM ET
10.79 Day range 10.79
52-week range unavailable
- YTD
- +7.79%
- 1 year
- +7.79%
News
globenewswire.com Columbus Circle Capital Corp II Announces Elroy Air Was Awarded an Up to $46M Contract with U.S. Army SAN FRANCISCO, CA, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp II (Nasdaq: CMII), a special purpose acquisition company led by the management team of Inflection Point Asset…
globenewswire.com Columbus Circle Capital Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026 New York, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp II (Nasdaq: CMIIU) (the “Company”) announced today that, commencing February 27, 2026, holders of the units sold in the…
globenewswire.com Columbus Circle Capital Corp. II and Cohen & Company Inc. Announce Completion of $230,000,000 Initial Public Offering New York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp. II (Nasdaq: CMIIU) (the “Company”) and Cohen & Company Inc. (NYSE American: COHN) (“Cohen & Company”) today announced the…
globenewswire.com Columbus Circle Capital Corp II Announces Pricing of $200,000,000 Initial Public Offering New York, NY, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp II (NASDAQ: CMIIU) (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a…
seekingalpha.com U.S. IPO Weekly Recap: Equipment Rental Rises While Crypto Company Crashes In 2-IPO Week Two operating companies priced IPOs this week, along with six SPACs. Ten issuers submitted initial filings this week, with five operating companies and five SPACs. Four IPOs are currently scheduled…
globenewswire.com SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies BOULDER, Colo. & SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist…
gurufocus.com ARK Investment Leans Into Biotech and Telecom Holdings Catherine Wood (Trades, Portfolio)'s ARK Investment has revealed additions to three biotechnology and telecommunications holdings according to GuruFocus' Real-Time Picks, a Premium feature.
businesswire.com SomaLogic Customizable Protein Panels With Industry-Leading 7,000-Plex Assay Now Available NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein…
gurufocus.com SomaLogic Latest to Take SPAC Route to Public Markets SomaLogic is joining the growing number of companies going public via special purpose acquisition companies. The Boulder, Colorado-based health care company plans to merge with CM Life Sciences II…
businesswire.com CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $240 Million Initial Public Offering NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (the “Company”) announced today that it priced its initial public offering of 24,000,000 units at $10.00 per unit. The units will be listed on The…